The global respiratory inhaler devices market share analysis is witnessing steady growth, with a projected increase from USD 41,037.3 Million in 2025 to USD 66,329.8 Million by 2035, despite a CAGR of ~4.9%. The market remains moderately concentrated, with the top 10 players accounting for approximately 54.8% of the total market share. GSK plc leads …